Novo Nordisk 9-month Profit Rises - Quick Facts

(RTTNews) - Novo Nordisk (NVO) reported that its nine-month pretax profit increased to DKK 24.75 billion, from DKK 20.36 billion, last year. Net profit was DKK 19.13 billion, compared to DKK 15.68 billion, a year ago. Earnings per share/ADR, increased to DKK 35.39, from DKK 28.32, previous year.

Sales increased year-over-year to DKK 61.87 billion, from DKK 57.06 billion.

Novo Nordisk now expects its 2013 net financial income of around DKK 1.10 billion, compared to prior guidance of income of around DKK 900 million. Sales growth for 2013 is still expected to be 11%-13% measured in local currencies. Given the current level of exchange rates versus the Danish krone, Novo Nordisk now expects the reported sales growth to be around 4.5 percentage points lower than growth measured in local currencies.